Physician profile
Corey A Gilbert
NPI 1366684417
$7,412.28
in general payments reported to CMS, 2019-2025
10 companies · $4,264 in 2025
The $4,264 reported for 2025 was more than what 79% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $318 · 2024: $2,831 · 2025: $4,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,147 · Food and Beverage: $3,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,146.62 |
| Food and Beverage | $3,265.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,977.06 | 2023-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Aetos Shoulder System, Microraptor |
| Arthrex, INC. | $2,032.33 | 2023-2025 | |
| Supreme Orthopedic Systems, LLC | $1,284.77 | 2023-2025 | |
| Stryker Corporation | $711.86 | 2024-2025 | Triathlon, 1788, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $196.71 | 2024 | Tapestry |
| Depuy Synthes Sales INC. | $85.53 | 2025 | Monovisc |
| Maxx Orthopedics, INC. | $51.58 | 2024 | |
| Mimedx Group, INC. | $38.41 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $19.75 | 2025 | Exparel, Zilretta |
| Solventum Corporation | $14.28 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.